These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 27544756)

  • 1. The Association between Angiotensin Receptor Blocker Usage and Breast Cancer Characteristics.
    Goldvaser H; Rizel S; Hendler D; Neiman V; Shepshelovich D; Shochat T; Sulkes A; Brenner B; Yerushalmi R
    Oncology; 2016; 91(4):217-223. PubMed ID: 27544756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis Risk Reduction Related with Beta-Blocker Treatment in Mexican Women with Breast Cancer.
    Parada-Huerta E; Alvarez-Dominguez T; Uribe-Escamilla R; Rodriguez-Joya J; Ponce-Medrano JD; Padron-Lucio S; Alfaro-Rodriguez A; Bandala C
    Asian Pac J Cancer Prev; 2016; 17(6):2953-7. PubMed ID: 27356717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between smoking and breast cancer characteristics and outcome.
    Goldvaser H; Gal O; Rizel S; Hendler D; Neiman V; Shochat T; Sulkes A; Brenner B; Yerushalmi R
    BMC Cancer; 2017 Sep; 17(1):624. PubMed ID: 28874120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer.
    Chen L; Malone KE; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1423-6. PubMed ID: 26084603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients.
    Arslan UY; Turker I; Aksoy S; Oksuzoglu B; Helvaci K; Yildirim Ozdemir N; Uyeturk U; Uysal Sonmez O; Budakoglu B; Zengin N
    J BUON; 2013; 18(3):585-93. PubMed ID: 24065468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy.
    Wong H; Lau S; Cheung P; Wong TT; Parker A; Yau T; Epstein RJ
    BMC Cancer; 2014 Nov; 14():826. PubMed ID: 25385074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and morphological features and treatment for lobular breast cancer].
    Tabagua TT; Semiglazov VV; Bus'ko EA; Semiglazova TIu; Voroshnikov VV
    Vopr Onkol; 2013; 59(3):386-9. PubMed ID: 23909043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival.
    Winn JS; Baker MG; Fanous IS; Slack-Davis JK; Atkins KA; Dillon PM
    Oncology; 2016; 91(3):135-42. PubMed ID: 27355204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast conservative surgery and local recurrence.
    Rezai M; Kraemer S; Kimmig R; Kern P
    Breast; 2015 Nov; 24 Suppl 2():S100-7. PubMed ID: 26432359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
    Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2-positive breast cancer patients: correlation between mammographic and pathological findings.
    Radenkovic S; Konjevic G; Isakovic A; Stevanovic P; Gopcevic K; Jurisic V
    Radiat Prot Dosimetry; 2014 Nov; 162(1-2):125-8. PubMed ID: 25063784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival.
    Ishihara M; Mukai H; Nagai S; Onozawa M; Nihei K; Shimada T; Wada N
    Oncology; 2013; 84(3):135-40. PubMed ID: 23235554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis.
    Raimondi S; Botteri E; Munzone E; Cipolla C; Rotmensz N; DeCensi A; Gandini S
    Int J Cancer; 2016 Jul; 139(1):212-9. PubMed ID: 26916107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy.
    Steely AM; Callas PW; Bertges DJ;
    J Vasc Surg; 2016 Mar; 63(3):715-21. PubMed ID: 26603543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.